A challenge for pediatric urology is the surgical treatment of birth defects of the lower urinary and genitourinary tract in boys. While genitourinary birth defects are among the most common diagnosed, the molecular basis of these defects is lacking. This application seeks support to continue our investigations into the genomic basis of these birth defects. We used state-of-the-art technology, comparative genomic hybridization microarray (aCGH), to identify submicroscopic gains or losses on chromosomes in children with congenital genitourinary defects. This work identified chromosomal regions where unrelated patients with the same birth defect exhibited de novo structural chromosomal duplications or deletions too small to be seen on a karyotype. A clinically validated aCGH identified structural chromosome defects in about 20% of children with genitourinary birth defects-an advance that can be used today by pediatric urologists. Thus our first hypothesis is proven: we improved the diagnosis of these children with aCGH. We seek to continue to identify genetic hotspots for congenital genitourinary defects. Importantly, the work identified a number of candidate genes for both normal human genitourinary development and birth defects. Based upon the current studies, we have a number of candidate genes for human urogenital tract development remaining to be analyzed and our aCGH studies continue to be informative and to suggest new areas for investigation. Accordingly, our specific aims remain similar to our currently funded proposal. We seek to identify the genetic and genomic defects that underlie these common birth defects. We will continue to show gene specific causality, beyond simple association with a birth defect, through generation of mouse models and definition of gene function during tissue morphogenesis. The long-term goal of this study is to improve the diagnosis of congenital genitourinary defects and to define the genetic basis for the failure of this key biologic process for children with birth defects of the urogenital tract. Although most urogenital tract defects are surgically corrected in children by the pediatric urologist, we seek t understand the cause of the birth defect and to know the likelihood whether any future children will be similarly afflicted. This proposal uses novel approaches to improve both our understanding of the molecular basis and to improve our ability to diagnose these common birth defects of the lower urinary and genitourinary tracts.

Public Health Relevance

Although most urogenital tract defects are surgically corrected in children by the pediatric urologist, we seek to understand the cause of the birth defect and to know the likelihood whether any future children will be similarly afflicted. This proposal uses novel approaches to improve both our understanding of the molecular basis and to improve our ability to diagnose these common birth defects of the lower urinary and genitourinary tracts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK078121-08
Application #
8913143
Study Section
Urologic and Genitourinary Physiology and Pathology (UGPP)
Program Officer
Rasooly, Rebekah S
Project Start
2007-09-15
Project End
2016-08-31
Budget Start
2015-09-01
Budget End
2016-08-31
Support Year
8
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Baylor College of Medicine
Department
Urology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Thirumavalavan, Nannan; Scovell, Jason M; Balasubramanian, Adithya et al. (2018) The Impact of Microsurgical Repair of Subclinical and Clinical Varicoceles on Total Motile Sperm Count: Is There a Difference? Urology 120:109-113
Thirumavalavan, Nannan; Scovell, Jason M; Link, Richard E et al. (2018) Does Solid Organ Transplantation Affect Male Reproduction? Eur Urol Focus 4:307-310
Haller, Meade; Au, Jason; O'Neill, Marisol et al. (2018) 16p11.2 transcription factor MAZ is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A 115:E1849-E1858
Haller, Meade; Mo, Qianxing; Imamoto, Akira et al. (2017) Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development. Proc Natl Acad Sci U S A 114:4981-4986
Bekheirnia, Mir Reza; Bekheirnia, Nasim; Bainbridge, Matthew N et al. (2017) Whole-exome sequencing in the molecular diagnosis of individuals with congenital anomalies of the kidney and urinary tract and identification of a new causative gene. Genet Med 19:412-420
Chiba, Koji; Ramasamy, Ranjith; Lamb, Dolores J et al. (2016) The varicocele: diagnostic dilemmas, therapeutic challenges and future perspectives. Asian J Androl 18:276-81
Gomez, Lissette; Kovac, Jason R; Lamb, Dolores J (2015) CYP17A1 inhibitors in castration-resistant prostate cancer. Steroids 95:80-7
Jorgez, Carolina J; Wilken, Nathan; Addai, Josephine B et al. (2015) Genomic and genetic variation in E2F transcription factor-1 in men with nonobstructive azoospermia. Fertil Steril 103:44-52.e1
Jorgez, Carolina J; Rosenfeld, Jill A; Wilken, Nathan R et al. (2014) Genitourinary defects associated with genomic deletions in 2p15 encompassing OTX1. PLoS One 9:e107028
Kovac, Jason R; Rajanahally, Saneal; Smith, Ryan P et al. (2014) Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med 11:553-62

Showing the most recent 10 out of 28 publications